Related Experiment Video

Updated: Sep 26, 2026

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo
08:53

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo

Published on: January 10, 2025

Congenital dyserythropoietic anemia type II: exclusion of seven candidate genes

Carmela Lanzara1, Romina Ficarella, Angela Totaro

  • 1TIGEM (Telethon Institute of Genetics and Medicine), 80131 Naples, Italy.

Blood Cells, Molecules & Diseases
|April 2, 2003
PubMed

Insights

Researchers investigated seven candidate genes for Congenital Dyserythropoietic Anemia II (CDA II), also known as HEMPAS. The study excluded these genes as the cause of CDA II, advancing the search for the causative gene.

Area of Science:

  • Genetics
  • Hematology
  • Molecular Biology

Background:

  • Congenital dyserythropoietic anemias (CDA) are inherited blood disorders affecting red blood cell production.
  • CDA is classified into types I, II, and III, with known genetic loci for each.
  • CDA II, or HEMPAS, is linked to chromosome 20q11.2.

Purpose of the Study:

  • To identify the causative gene for Congenital Dyserythropoietic Anemia II (CDA II).
  • To perform a mutational search within seven candidate genes located on chromosome 20q11.2 in CDA II patients.

Main Methods:

  • Genetic analysis of seven candidate genes in a cohort of CDA II patients.
  • Investigated genes included integrin beta 4 binding protein, ribophorin II, and others.
  • Utilized mutational search and DNA polymorphism analysis.

Main Results:

  • No causative mutations were found in the seven investigated genes for CDA II.
  • Several protein variants and DNA polymorphisms were identified.
  • The study effectively excluded the investigated genes as the cause of CDA II.

Conclusions:

  • The seven candidate genes examined are not responsible for causing CDA II.
  • This research contributes valuable information towards the ongoing cloning of the CDA II gene.
  • Further genetic investigations are required to pinpoint the etiology of CDA II.

More Related Videos

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

Related Concept Videos

Translation01:37

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.Translation Produces the Building Blocks of LifeProteins are called the...
Translation01:37

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.Translation Produces the Building Blocks of LifeProteins are called the...
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Pleiotropy01:47

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...